Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.23NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.134NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.39.1.3 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.3.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
C.38NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBC.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Q.2 (Alpha)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BL.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
M.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
C.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.82 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
A.30NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.35NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.23.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.466.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.75.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBHNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BL.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.1.78NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.9.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.1.64NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBC.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.221.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
DP.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BL.1.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.62NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.82NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.20NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.3.22NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.38.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.79.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.47NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.7.18NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XAY.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-18248.7Germany
BQ.1.1.55NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BY.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EA.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XJNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BR.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBF.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.1.29NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CM.5.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CM.8.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBSNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.2.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XAHNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBJ.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used